Targeted Therapies and other Agents as First-Line Maintenance and Beyond: Particular Benefit in Pulmonary Adenocarcinoma Patients
Journal:
Current Medicinal Chemistry
Volume:
18
Page:
1640-1650
Author(s):
F. Petrelli, K. Borgonovo, M. Cabiddu, M. Ghilardi and S. Barni
Drugs of Abuse: Epigenetic Mechanisms in Toxicity and Addiction
Journal:
Current Medicinal Chemistry
Volume:
18
Page:
1765-1774
Author(s):
L. Kovatsi, D. Fragou, V. Samanidou, S. Njau and S. Kouidou
PET Tracers Based on Zirconium-89
Journal:
Current Radiopharmaceuticals
Volume:
4
Page:
131-139
Author(s):
Yin Zhang, Hao Hong and Weibo Cai
The Targets of Curcumin
Journal:
Current Drug Targets
Volume:
12
Page:
332-347
Author(s):
Hongyu Zhou, Christopher S. Beevers and Shile Huang
Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives
Journal:
Current Cancer Drug Targets
Volume:
11
Page:
239-253
Author(s):
D. Chen, M. Frezza, S. Schmitt, J. Kanwar and Q. P. Dou
Marizomib, a Proteasome Inhibitor for All Seasons: Preclinical Profile and a Framework for Clinical Trials
Journal:
Current Cancer Drug Targets
Volume:
11
Page:
254-284
Author(s):
G. K. Lloyd, M. A. Palladino, A. Younes, E. Valashi, M. A. Spear, C. M. Sloss, A. M. Roccaro, P. G. Richardson, F. Pajonk, H. Ovaa, Y. Oki, S. T.C. Neuteboom, C. P. Miller, D. J. McConkey, W. McBride, B. C. Potts, K. S. Lam, P. R. Jensen, M. Groll, I. M. Ghobrial, W. Fenical, J. C. Cusack, D. Chauhan, J. Chandra, B. Bonavida, C. Berkers, S. Baritaki, K. C. Anderson and M. X. Albitar
Green Tea Polyphenols as Proteasome Inhibitors: Implication in Chemoprevention
Journal:
Current Cancer Drug Targets
Volume:
11
Page:
296-306
Author(s):
H. Yang, K. Landis-Piwowar, T. H. Chan and Q. P. Dou
Autophagy: Molecular Mechanisms and their Implications for Anticancer Therapies
Journal:
Current Cancer Drug Targets
Volume:
11
Page:
357-379
Author(s):
S. Meschini, M. Condello, P. Lista and G. Arancia
The Many Faces of Glutathione Transferase Pi
Journal:
Current Molecular Medicine
Volume:
11
Page:
129-139
Author(s):
O. Vasieva
Non-Genotoxic p53-Activators and their Significance as Antitumor Therapy of Future
Journal:
Current Medicinal Chemistry
Volume:
18
Page:
1038-1049
Author(s):
S. K. Nayak, P. S. Panesar and H. Kumar